4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Eikon Therapeutics, Inc. (EIKN) operates in the Biotechnology industry and is headquartered in Millbrae, United States with about 384 employees. Its market capitalization is roughly $592 million. In the fiscal year ended 2025-12-31, EIKN reported $0M in revenue and ($324M) in net income.
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenue | $0M | $0M | $0M |
| Operating Income (EBIT) | ($339M) | ($260M) | ($266M) |
| Net Income | ($324M) | ($244M) | ($242M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($87M) | ($83M) | ($71M) | ($68M) |
| Net Income | ($83M) | ($80M) | ($68M) | ($65M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Assets | $595M | $491M | $526M |
| Total Liabilities | $1.5B | $1.1B | $867M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EIKN viewer.
About TickerBase · Data methodology & sources